Psoriasis and Mental Health: Why Whole-Patient Care Matters
On the Frontlines of PsoriasisPsoriasis and Mental Health: Why Whole-Patient Care Matters
Steve Jackson, PharmD
The Future of Pediatric Atopic Dermatitis Treatment
On the Frontlines of Pediatric Skin HealthThe Future of Pediatric Atopic Dermatitis Treatment
Brian P. McDonough, MD, FAAFP
Mercedes Gonzalez, MD
When Is It Time to Move Beyond Topicals in Pediatric Atopic Dermatitis?
On the Frontlines of Pediatric Skin HealthWhen Is It Time to Move Beyond Topicals in Pediatric Atopic Dermatitis?
Brian P. McDonough, MD, FAAFP
Mercedes Gonzalez, MD
The Evolving Science of Chronic Spontaneous Urticaria
On the Frontlines of Chronic Spontaneous UrticariaThe Evolving Science of Chronic Spontaneous Urticaria
Gates B. Colbert, MD
Gordon Sussman, MD, FRCPC, FACP, FAAAAI
IL-31’s Role in Atopic Dermatitis and Prurigo Nodularis: Neuroimmune Insights
DermConsultIL-31’s Role in Atopic Dermatitis and Prurigo Nodularis: Neuroimmune Insights
Raj Chovatiya, MD, PhD, MSCI, FAAD
Nicholas Mollanazar, MD
Personalizing Systemic Therapy in Atopic Dermatitis and Prurigo Nodularis
DermConsultPersonalizing Systemic Therapy in Atopic Dermatitis and Prurigo Nodularis
Raj Chovatiya, MD, PhD, MSCI, FAAD
Peter A. Lio, MD
- advertisement
The IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
CME/CEThe IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
Anthony Fernandez, MD, PhD
Case Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
CME/CECase Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
Carole Bitar, MD, FAAD
Matthew P. Giannetti, MD
Benjamin Ungar, MD
Calming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
CME/CECalming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
April W. Armstrong, MD, MPH
Melinda Gooderham, MSc, MD, FRCPC
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CELiving With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
CME/CEVous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
- advertisement
Integrating Patient Perspectives in Dermatologic Care
DermConsultIntegrating Patient Perspectives in Dermatologic Care
Mona Shahriari MD, FAAD
Linda Stein Gold, MD
Jennifer Soung, MD
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Medical Industry FeatureLiving with Psoriatic Arthritis: A Doctor-Patient Conversation
Elizabeth Perkins, MD
Dawn Carter
Understanding Dual Inhibition of IL-17
Medical Industry FeatureUnderstanding Dual Inhibition of IL-17
Bret Sohn, MD
Eric Anderson, MD
- 06/01/2026
- 05/18/2026
- 05/16/2026
- 05/07/2026
- 05/05/2026
- 04/29/2026